Navigation Links
Varian Medical Systems Books $88 Million Order to Equip Proton Treatment Center
Date:10/3/2011

PALO ALTO, Calif., Oct. 3, 2011 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced it has booked an $88 million order to provide its ProBeam system for the Scripps Proton Therapy Center being developed in San Diego through collaboration between Scripps Health, Scripps Clinic Medical Group and Advanced Particle Therapy, of Nevada.  The equipment order for the five room center that will be operated by Scripps Health was issued by the California Proton Treatment Center (CPTC), a special purpose entity formed by Advanced Particle Therapy which is acting as developer for the $225 million project.  Concurrent with the order booking in the fourth quarter of fiscal year 2011, Varian has also recorded revenue for this equipment under the "percentage of completion method."

Varian has also signed a 10-year agreement valued at approximately $60 million to service its ProBeam system for the center which is currently under construction and scheduled to open in 2013.  Service revenue will be recorded in the future over the life of the contract and has not been added to the company's backlog.

Varian is partnering with ORIX Capital Markets of Dallas in a $165 million loan facility to finance the completion and startup operations of the new center.  Varian is participating in the credit facility with a $115 million loan commitment through its subsidiary in Switzerland and ORIX is making a $50 million loan commitment. The loan carries a minimum interest rate of 8.25 percent with a four-year term and two possible one-year extensions.  ORIX, which is the loan agent for the facility, will endeavor to syndicate up to approximately 60 percent of Varian's loan commitment. Advanced Particle Therapy ha
'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... and DEKALB, Ill. , May ... Letter of Intent to explore an affiliation with ... months, KishHealth and NMHC will further define the ... approval. "KishHealth is recognized for their ... said Dean M. Harrison , President and ...
(Date:5/28/2015)... , May 28, 2015 ... has announced the addition of Jain PharmaBiotech,s ... Commercial Aspects"  to their offering.  ,     (Logo: ... or individualized treatment is to match the ... in some cases, even to design the ...
(Date:5/28/2015)... -- Eli Lilly and Company (NYSE: LLY ) and ... on June 11 to discuss data from the first two ... these two trials, RA-BEACON and RA-BUILD, will be presented on ... 2015 in Rome, Italy . ... Daylight Time. The live audio webcast can be accessed through ...
Breaking Medicine Technology:KishHealth System Explores Affiliation with Northwestern Memorial HealthCare 2KishHealth System Explores Affiliation with Northwestern Memorial HealthCare 3Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 2Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 3Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 2Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 3
... VIVUS, Inc. (Nasdaq: VVUS ) today announced ... with Meda - an international specialty pharma company - ... dysfunction (ED).  Under the agreement, Meda will acquire the ... patents, existing inventory and the manufacturing facility located in ...
... The National Community Pharmacists Association (NCPA) ... dedicated to advancing the interests of independent long-term ... http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ) (Logo:   http://www.newscom.com/cgi-bin/prnh/20100106/DC33253LOGO ) ... for independent community pharmacies and their patients," said ...
Cached Medicine Technology:VIVUS Announces Sale of MUSE Assets to Meda 2VIVUS Announces Sale of MUSE Assets to Meda 3NCPA Announces New Division Dedicated to Long-Term Care Pharmacies, Patients 2NCPA Announces New Division Dedicated to Long-Term Care Pharmacies, Patients 3
(Date:5/29/2015)... May 29, 2015 AMIA Issues Report ... management of medical data. , Today AMIA released the ... Records (EHR). The “ Report of the AMIA ... Direction of EHRs ” was released in the Journal ... and represents an evolutionary approach in the ...
(Date:5/29/2015)... Georgia (PRWEB) May 29, 2015 National ... celebration for Swedish nationals around the world. The celebration held ... Atlanta and in cooperation with SWEA (Swedish Women’s ... of the year for the Swedish-American community in Georgia. , ... this celebration of Swedish heritage and the long relationship between ...
(Date:5/29/2015)... New England Peptide, Inc. (NEP), in ... Analysis Consortium (CPTAC) and others, today announced the ... of peptide stable isotope standards for biomarker discovery. ... tryptic peptides, offers thousands of fragments spanning over ... accessible to the biomedical research community. Each ...
(Date:5/28/2015)... VA (PRWEB) May 29, 2015 ... Practices and Innovative Approaches, **FDAnews Webinar**, June 23, ... http://www.fdanews.com/MDCybersecurityQA , Network connectivity opens up ... it also exposes a minefield of potential liabilities. ... healthcare professionals, but can manufacturers be sure the ...
(Date:5/28/2015)... 2015 External Counterpulsation (EECP/ECP) has been ... the United States. There are a growing number of ... experience symptoms of angina and these patients are often ... bypass surgery. , “No option” patients are a sizable ... disease that is considered unacceptable for heart stent or ...
Breaking Medicine News(10 mins):Health News:AMIA Issues Report on Electronic Health Records - EHR-2020 2Health News:AMIA Issues Report on Electronic Health Records - EHR-2020 3Health News:PartnerTech Co-Sponsors National Sweden Day Hosted by SACC-Georgia 2Health News:PartnerTech Co-Sponsors National Sweden Day Hosted by SACC-Georgia 3Health News:New England Peptide Announces New Tryptides™ Catalog 2Health News:New England Peptide Announces New Tryptides™ Catalog 3Health News:FDAnews Announces — Medical Device Cybersecurity Quality Assurance: Requirements, Best Practices and Innovative Approaches Webinar, June 23, 2015 2Health News:FDAnews Announces — Medical Device Cybersecurity Quality Assurance: Requirements, Best Practices and Innovative Approaches Webinar, June 23, 2015 3Health News:External Counterpulsation (EECP/ECP) a New Heart Disease Therapy Helps People of Calgary with Unstable Angina 2
... (February 9, 2012) In a study to be presented ... Pregnancy Meeting , in Dallas, Texas, researchers will report findings ... are more likely to have a subsequent baby that is ... is carried to term. While there is much ...
... Fla. Moffitt Cancer Center, Sanford-Burnham Medical Research ... collaborate on the creation of a Personalized Medicine ... conduct collaborative research to accelerate discovery and develop ... metabolic diseases, including obesity, diabetes and cardiovascular disease. ...
... search for new, better ways to diagnose periprosthetic joint ... measurement of C-reactive protein in the synovial fluid is ... cell count (WBC) and the percentage of neutrophils (PMN%), ... in the determination of PJI. , The synovial fluid ...
... companion dogs with advanced-stage non-Hodgkin lymphoma (NHL) has been ... according to a study published in the journal ... between The University of Texas MD Anderson Children,s Cancer ... Veterinary Medicine in College Station. Using a T-cell ...
... , TUESDAY, Feb. 7 (HealthDay News) -- Surgery ... among people with epilepsy, according to a study stretching ... the longest follow-up of epilepsy surgery patients in that ... eras of neuroimaging [brain-scanning] techniques," said Dr. Cynthia Harden, ...
... Mann HealthDay Reporter , MONDAY, Feb. 6 (HealthDay ... not seem to be at increased risk of readmission to ... trimester, a new study suggests. The findings, which appear ... Psychiatry , support several previous studies showing that women who ...
Cached Medicine News:Health News:Study finds prior preterm delivery indicates subsequent baby will be small even if carried to term 2Health News:Moffitt, Sanford-Burnham and Florida Hospital create Personalized Medicine Partnership of Florida 2Health News:Moffitt, Sanford-Burnham and Florida Hospital create Personalized Medicine Partnership of Florida 3Health News:UT MD Anderson, Texas A&M team up to treat canine lymphoma 2Health News:UT MD Anderson, Texas A&M team up to treat canine lymphoma 3Health News:Surgery Effective for Tough-to-Treat Epilepsy 2Health News:Does Abortion in First Trimester Raise Risk of Mental Ills' Return? 2Health News:Does Abortion in First Trimester Raise Risk of Mental Ills' Return? 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: